Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|June 6, 2018
An Update on MDMX and Dual MDM2/X InhibitorsMargarida Espadinha, Valentina Barcherini, Elizabeth A Lopes, et al.
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Tryptophanol-Derived Oxazolopyrrolidone Lactams as Potential Anticancer Agents against Gastric AdenocarcinomaMargarida Espadinha, Valentina Barcherini, Lídia M Gonçalves, et al.
International Journal of Molecular Sciences|January 23, 2020
SLMP53-1 Inhibits Tumor Cell Growth through Regulation of Glucose Metabolism and Angiogenesis in a P53-Dependent MannerHelena Ramos, Juliana Calheiros, Joana Almeida, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 ActivatorsValentina Barcherini, Joana B Loureiro, Ana Sena, et al.
Chemmedchem|August 2, 2020
Potency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal CancerValentina Barcherini, Joana Almeida, Elizabeth A Lopes, et al.
European Journal of Medicinal Chemistry|October 6, 2024
First fragment-based screening identifies new chemotypes inhibiting ERAP1-metalloproteaseVasileios Fougiaxis, Valentina Barcherini, Milena M Petrovic, et al.
ACS Pharmacology & Translational Science|June 19, 2025
Mechanistic Insights of a p53-Targeting Small MoleculeRicardo J F Ferreira, Valentina Barcherini, Catarina Roma-Rodrigues, et al.
Cancers|April 30, 2021
Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic ResistanceJoana B Loureiro, Liliana Raimundo, Juliana Calheiros, et al.
Biochimica Et Biophysica Acta. General Subjects|September 20, 2019
SLMP53-1 interacts with wild-type and mutant p53 DNA-binding domain and reactivates multiple hotspot mutationsAna Sara Gomes, Helena Ramos, Sara Gomes, et al.
Pageof 1